FundingCommerce & Consumer Brands
Pee Safe raises $32M from OrbiMed
By Abha Lohia · Editor ·
Pee Safe: revenue and funding and every story →
growthFounded 2013
- Pee Safe makes women's hygiene products like intimate washes and organic cotton tampons
- It raised about $32 million in growth capital from healthcare-focused private equity firm OrbiMed
- The round includes a secondary sale, giving partial exits to early investors
What happened
- Pee Safe raised about $32 million (INR 290 crore) in growth capital from OrbiMed, a global healthcare-focused private equity firm.
- The round is a mix of primary shares (new money to the company) and secondary shares (existing shareholders selling their shares).
- Early investors are making a partial exit through the secondary sale.
- Dr Sunny Sharma (Senior Managing Director, OrbiMed Asia) and Sumona Chakraborty (Executive Director) join Pee Safe's board.
- The company plans to use the funds to expand offline retail, strengthen brand-led marketing, and accelerate growth on quick commerce and marketplaces.
Why it matters
- The femtech market globally was worth $60.2 billion in 2024 and is expected to grow at a CAGR of 16% over the next decade.
- OrbiMed manages about $20 billion across public and private investments and has backed Indian companies like Kapiva, Innvolution Healthcare, and Marksans Pharma.
- Competitors include Sirona, Sanfe, Nua Women, Plush, Johnson & Johnson, and Procter & Gamble.
The business
- Pee Safe is a women's hygiene and wellness brand offering products for toilet hygiene, feminine/intimate hygiene, personal care, grooming, and wellness.
- Its product range includes organic cotton tampons, breast pads, panty liners, intimate wash (for men and women), wipes, maternity care, and anti-pollution dust masks.
- The company has a presence across 50,000+ offline retail touchpoints in 100+ cities and 23 international markets.
- It achieved an annualised net revenue run rate (NRR) of over INR 150 crore.
- In FY25, revenue from operations was INR 82 crore, up 46% from INR 56 crore in FY24.
- Its loss narrowed to INR 4 crore in FY25, down 69% from INR 13 crore in FY24.
The founders
VB
Vikas Bagaria
co-founder- Co-founded Pee Safe in 2017 with Rithish Kumar and Srijana Bagaria.
- No further background details available in the facts.
RK
Rithish Kumar
co-founder- Joined as co-founder in 2017.
- No further background details available in the facts.
SB
Srijana Bagaria
co-founder- Co-founded Pee Safe in 2013 with Vikas Bagaria.
- No further background details available in the facts.
Who put in money
- OrbiMed lead — Global healthcare-focused private equity firm managing about $20 billion.
In numbers
INR 150 CrAnnualised net revenue run rate
INR 82 CrRevenue from operations · FY25
INR 56 CrRevenue from operations · FY24
INR 4 CrLoss · FY25
INR 13 CrLoss · FY24
50,000+Offline retail touchpoints
100+Cities
23International markets
What happens next
- Expand offline retail footprint.
- Strengthen brand-led marketing.
- Accelerate growth across quick commerce and leading marketplaces.
Earlier rounds
- 2023 · $3M · led by Natco Pharma and Rainmatter Health
- $16.5M (total prior to this round) · led by Alkemi Growth Capital
Up against
SironaSanfeNua WomenPlushJohnson & JohnsonProcter & Gamble
Words to know
- Primary shares
- New shares issued by the company to raise capital; the money goes to the company.
- Secondary shares
- Existing shareholders sell their shares to new investors; the money goes to the sellers, not the company.
- Growth capital
- Investment in a mature company to help it expand, often through a mix of primary and secondary shares.
- Net revenue run rate (NRR)
- Annualised revenue based on recent monthly or quarterly performance, used to estimate current scale.
The numbers around it
Commerce & Consumer Brands in January 2026: 32 rounds with a disclosed amount, $292 million in all; the biggest was iD Fresh (₹1,300 Cr). Every sector this year →
Other articles talking about it
indian-startup-times ↗Indian Startup Times ↗Mint ↗Inc42 ↗Entrackr ↗Indian Startup News ↗Inc42 ↗Entrackr ↗Inc42 ↗Entrackr ↗
Terms in this story
- Private equity: Venture capital backs young companies that could grow very fast, taking small stakes and accepting that many will fail, while private equity backs mature companies, often with large or controlling stakes and steadier returns. In India both usually invest through SEBI-registered AIFs, with venture capital funds in Category I and most private equity in Category II.
- Secondary sale: A secondary sale is when existing shareholders sell shares to someone else, so the money goes to the sellers and not to the company. It lets founders, early investors and employees get cash without an IPO or acquisition, and gains on unlisted shares held over 24 months are taxed at 12.5%.
- Primary and secondary funding: In a primary round, a startup issues new shares and the money goes into the company. In a secondary sale, existing shareholders sell their shares to a new buyer and the money goes to those sellers, not to the company. Many headline amounts combine both.
Read next
LaunchBlinkit starts ambulance service in BengaluruBlinkit is a quick-commerce app that delivers groceries and household items in minutes, and also runs an emergency ambulance servicePartnershipAtomberg and Voltas sign AC compressor ventureAtomberg makes energy-saving home appliances and has an Airtech subsidiary meant to build components for room air conditionersFundingBoba Bhai raises $18 million Series BBoba Bhai is a Bengaluru quick-service chain selling bubble tea and Korean street food
Everything on Pee Safe → · All startup news on 14 January 2026 →
Is this Pee Safe? Get your “Featured on StopDown” badge →